🇺🇸 FDA
Pipeline program

aspirin and atorvastatin

0719

Phase 2 small_molecule active

Quick answer

aspirin and atorvastatin for Cardiovascular Risk Factor is a Phase 2 program (small_molecule) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).

Program details

Company
UNITED THERAPEUTICS Corp
Indication
Cardiovascular Risk Factor
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials